Preparation of protective antigen from bacillus anthracis

Details for Australian Patent Application No. 2005254774 (hide)

Owner Health Protection Agency Dynport Vaccine Company LLC

Inventors Solow, Barbara T.; McEntee, Ian; Vincent, Philip; Arroyo, Juan; Jack, George; Herbert, Michael; Allison, Nigel; Brehm, John; Brehm, Rossalyn; Lapcevich, Randall K.

Agent Freehills

Pub. Number AU-B-2005254774

PCT Pub. Number WO2005/123764

Priority 11/153,865 15.06.05 US; 0413475.5 16.06.04 GB; 60/579,687 16.06.04 US

Filing date 16 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 6 January 2011

International Classifications

C07K 14/32 (2006.01) Peptides having more than 20 amino acids

A61K 39/07 (2006.01) Medicinal preparations containing antigens or antibodies - Bacillus

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123764 Priority application(s): WO2005/123764

6 January 2011 Application Accepted

  Published as AU-B-2005254774

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254779-Well treatment

2005254771-Substituted quinazolones as anticancer agents